Opioid-induced hyperalgesia and rapid opioid detoxification after tacrolimus administration

Anesthesia and Analgesia

Volumn 106, Issue 2, 2008, Pages 645-646

  Siniscalchi, Antonio ^b   Piraccini, Emanuele ^a,b   Miklosova, Zuzana ^a   Taddei, Stefania ^b   Faenza, Stefano ^a   Martinelli, Gerardo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AMITRIPTYLINE; CLONIDINE; CORTICOSTEROID; DIAZEPAM; GABAPENTIN; LORAZEPAM; METHADONE; MIDAZOLAM; MORPHINE; NALOXONE; OMEPRAZOLE; PROPOFOL; RANITIDINE; TACROLIMUS;

ADULT; ANXIETY DISORDER; ARTICLE; ASTHENIA; CASE REPORT; CONTINUOUS INFUSION; DROWSINESS; DRUG DETOXIFICATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; GENERAL ANESTHESIA; HUMAN; HYPERALGESIA; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE TRANSPLANTATION; LEG PAIN; NEUROPATHIC PAIN; PARESTHESIA; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; REFLEX DISORDER; SENSORIMOTOR NEUROPATHY; SINGLE DRUG DOSE; SPINAL CORD STIMULATION;

EID: 38549174043     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181602c3e     Document Type: Article

References (13)

1. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006;104:570-87
2. Masetti M, Cautero N, Lauro A, Di Benedetto F, Begliomini B, Siniscalchi A, Pironi L, Miglioli M, Bagni A, Pinna AD. Three-year experience in clinical intestinal transplantation. Transplant Proc 2004;36:309-11
3. Peltier AC, Russell JW: Recent Advances in drug-induced neuropathies. Curr Opin Neurol 2002;15:633-638
4. Bechstein WO. Neurotoxicity of calcineurin inhibitors impact and clinical management. Transpl Int 2000;13:313-26
5. Wijdicks E. Neurotoxicity of immunosuppressive drugs. Liver Transpl 2001;7:937-42
6. Ayres RC, Dousset B, Wixon S, Buckels JA, McMaster P, Mayer AD. Peripheral neurotoxicity with tacrolimus. Lancet 1994;343:862-3
7. Wilson JR, Conwit RA, Eidelman BH, Starzl T, Abu-Elmagd K. Sensorimotor neuropathy resembling CIDP in patients receiving FK506. Muscle Nerve 1994;17:528-32
8. Vadalouca A, Siafaka I, Argyra E, Vrachnou E, Moka E. Tharapeutic management of chronic neuropatic pain: an examination of pharmacologic treatent. Ann NY Acad Sci 2006;1088:164-86
9. Gilron I, Bailey JM, Dongsheng T, Holden RR, Weaver DF, Houlden R. Morphine, Gabapentin, or their combination for neuropathic pain. New Engl J Med 2005;352:1324-34
10. Costantini A. Spinal cord stimulation. Minerva Anestesiol 2005;71(7-8):471-4
11. Krabbe PF, Koning JP, Heinen N, Laheij RJ, Van Casuter RM, De Jong CA. Rapid detoxification from opioid dependence under general anesthesia versus standard methadone tapering: abstinence rates and withdrawal distress experiences. Addict Biol 2003;8:351-8
12. Favrat B, Zimmermann G, Zullino D, Krenz S, Dorogy F, Muller J, Zwahlen A, Besson J. Opioid detoxification under general anesthesia versus traditional clonidine detoxification combined with an additional week of psychosocial support: A randomized clinical trial. Drug Alcohol Dependence 2006;81:109-16
13. Gowing L, Ali R, White J: Opioid antagonist under heavy sedation or anesthesia for opioid withdrawal. Cochrane Database Syst Rev 2006;19:0020022